InsiderClue
Insiders · Profile

Tamayo Louis Edward

Chief Financial Officer at Lexeo Therapeutics. Filing since 1 Jul 2026. CIK 0002083206

Company
Date
Role
Action
Shares
Amount
Of holding
LXEO Lexeo Therapeutics, Inc.
18 Aug 2026
Chief Financial Officer
Sold at will
4,117
$20.20K
4.2%
LXEO Lexeo Therapeutics, Inc.
1 Jul 2026
Chief Financial Officer
Sold at will
4,641
$20.84K
4.6%
2 decisions on file.